Berlin, October 14-15
The leading networking event for rejuvenation startups, longevity investors, and translational researchers
The Rejuvenation Startup Summit (Berlin, Oct. 14-15, 2022) brought to you by the Forever Healthy Foundation, is a vibrant networking event that aims to accelerate the development of the rejuvenation biotech industry.
Rejuvenation/Longevity biotech is a new, emerging field of medicine. It aims to prevent and reverse diseases of aging by addressing their common root cause, the aging process itself. Rejuvenation therapies aim to reverse or repair age-related cellular changes such as molecular waste, calcification, tissue stiffening, loss of stem cell function, genetic alterations, and impaired energy production.
The Summit brings together startups, members of the longevity venture capital / investor ecosystem, and researchers interested in founding or joining a startup – all aiming to create therapies to vastly extend the healthy human lifespan.
In addition to an exciting range of keynotes, presentations, and panels, the summit features an all-day startup forum. Starting midday on Friday and finishing off on Saturday night with a big party, it offers ample opportunity to connect, learn and network with the most relevant players in the field.
Learn from the leading investors in the longevity space and get them interested in your approach. Connect to potential new team members. Present on-stage or in the all-day startup forum (limited availability). Panel discussions include participants from leading rejuvenation investors.
Researchers with a startup itch
Learn how to successfully break out of the lab and found or join a rejuvenation startup. Get tips from founders and institutions. Highlights include keynotes from selected speakers and panel discussions with successful founders.
Meet the most promising rejuvenation startups from all over the world, hear them present their approaches live on stage, and get in touch with them straight away.
Take the opportunity to meet the emerging rejuvenation biotech industry. Learn first hand from relevant players about this exciting new field that has the potential to become one of the biggest industries ever. For free media & press passes, please contact us at firstname.lastname@example.org
Michael Greve, CEO
Eric Verdin, CEO,
Brian Kennedy, Prof.
Alex Blyth, CEO
Christian Angermayer, mult. Founder (Apeiron, Rejuveron, Cambrian)
Patrick Burgermeister, Partner Kizoo Technology Capital
Silke Hüttner, CMO
Vlad Vitoc, CEO
Alex Schueller, CEO
Felix Frueh, CEO PAGE Therapeutics
Robin Mansukhani, CEO, Deciduous Therapeutics
Chris Shepard, CEO
Matthias Breugelmans, CEO Elastrin Therapeutics
Alexandra Bause, Apollo Health Ventures
Yuri Deigin, CEO
Naren Vyavahare, Prof. Clemson, CSO, Elastin Therapeutics
Mark Allen, CEO
Founding Partner maximon
Dobri Kiprov, Co-founder and CSO of Lyfspn
Pankaj Kapahi, Founder and CEO of Juvify
Aaron Cravens, CEO
James McCully, Co-founder of cellvie
Matthew O’Connor, CEO of Scientific Affairs at Cyclarity
Sophie Chabloz, Co-Founder and CPO of Avea
Oxana Polyakova, CSO LIfT BioSciences
Mike Kope, CEO of Corporate Affairs at
Peter Fedichev, CEO Gero
Rob Konrad Maciejewski, CEO
Joshua McClure, CEO
Mourad Topors, CSO
Stephen Helliwell, VP Discovery Biology at Rejuveron
Michael Sidler, Co-Founding Partner at Redalpine
Chris Rinsch, CEO and Co-founder of Amazentis
Lou Hawthorne, Founder and CEO NaNotics LLC
Cristiana Banlia, CTO Mitra Bio
Robert Cargill, CEO Glionics
Stephanie Dainow, Executive Director, Lifespan.io
Hans S. Keirstead, Chairman of the Board, Immunis Inc.
Phil Newman, Founder and CEO Longevity.Technology
Matthew Rosen, President, CoRegen
Frank Schueler, Managing Director. Kizoo
Radialsystem, Holzmarktstraße 33, 10243 Berlin